Theravance Biopharma (TBPH) Revenue Growth (3y) (2016 - 2026)
Theravance Biopharma (TBPH) Revenue Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
0.73% |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
122.97% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
7.94% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Theravance Biopharma |
846.10 Mn |
451.44 Mn |
- |
19.33% |
| Date | Value |
|---|
| Mar 31, 2026 |
19.33% |
| Dec 31, 2025 |
19.50% |
| Sep 30, 2025 |
17.09% |
| Jun 30, 2025 |
33.34% |
| Mar 31, 2025 |
83.27% |
| Dec 31, 2024 |
7.86% |
| Sep 30, 2024 |
8.53% |
| Jun 30, 2024 |
3.35% |
| Mar 31, 2024 |
0.57% |
| Dec 31, 2023 |
-2.12% |
| Sep 30, 2023 |
-4.92% |
| Jun 30, 2023 |
-2.88% |
| Mar 31, 2023 |
90.79% |
| Dec 31, 2022 |
-60.63% |
| Sep 30, 2022 |
0.06% |
| Jun 30, 2022 |
-41.07% |
| Mar 31, 2022 |
-22.34% |
| Dec 31, 2021 |
-1.70% |
| Sep 30, 2021 |
0.92% |
| Jun 30, 2021 |
-18.06% |
